CaRMS is leaving X and this account will no longer be updated. We hope you will join us on our other platforms to stay informed about match cycle updates, match data releases, and much more.
We are aware of the technical issue in CaRMS Online and our IT staff are currently looking into this. We will continue to share updates here as we have them.
The Family Medicine program directors have decided to defer the use of the FM structured reference form until the 2022 R-1 match. It will not be used in the 2021 match. They've asked us to share the following message on their behalf.
The AFMC has released the following statement to highlight the importance of protecting the integrity of the national residency match. Read the full statement here bit.ly/3RYOoi1.
Tomorrow is Match Day for applicants in the first iteration of the 2024 R-1 Match! Learn how to access your results at 12:00 (noon) ET here bit.ly/2Z4q4jc. #CaRMSMatch
After consultation with the AFMC, the application deadline will be extended until at least 10:00 ET on Saturday, December 2. As our work on the system continues, we will provide further updates.
Tomorrow is Match Day for the 1st iteration of the 2023 R-1 Match! Learn how to access your results at 12:00 (noon) ET here bit.ly/2Z4q4jc. #CaRMSMatch
CaRMS board director Dr. @fa_rizzuti is helping flatten the curve to protect Canadians with the contact tracing model he and his team built in Alberta. To learn more visit: bit.ly/2VuAyqk.
We hear your concerns about the FM Structured Reference Form, and we have shared them with the AFMC, FM representatives, and other stakeholders to be addressed in the coming days.
Unfilled positions from the first iteration of the 2024 R-1 Match have now been posted on carms.ca. Find the list of positions here bit.ly/3IHtAWQ. #CaRMSMatch
CaRMS is deeply saddened by the tragic loss of one of the 2019 SBSAL winners, Mohammad Asadi-Lari, who was among the 176 people killed on UIA 752 near Tehran, Iran. A message from Dr. Eric Peters, Chair of CaRMS Board of Directors, can be read here: ow.ly/BklA50xStOU